Análisis farmacogenético para la estimación de la seguridad y eficacia en la respuesta a clopidogrel en pacientes con síndrome coronario agudo atendidos en MEDERI.

Medicina y ciencias biológicas

1. Acute Coronary Syndrome 38%
2. Alleles 51%
3. Aryldialkylphosphatase 40%
4. Blood Platelets 25%
5. Clopidogrel 100%
6. Confidence Intervals 6%
7. Coronary Artery Disease 25%
8. cytochrome P-450 CYP2C subfamily 6%
9. Cytochrome P-450 CYP2C19 70%
10. Disease Susceptibility 33%
11. Drug-Related Side Effects and Adverse Reactions 17%
12. Gene Frequency 21%
13. Genes 7%
14. Genetic Models 5%
15. Haplotypes 14%
16. HDL Lipoproteins 5%
17. Health 5%
18. Hemorrhage 7%
19. Linkage Disequilibrium 8%
20. Lipid Peroxides 6%
21. Medical Schools 7%
22. Medical Students 7%
23. Medicine 8%
24. Nucleic Acid Regulatory Sequences 8%
25. Nucleotides 6%
26. Odds Ratio 6%
27. origen 54%
28. Pharmaceutical Preparations 9%
29. Pharmacogenomic Testing 45%
30. Population 20%
31. Precision Medicine 8%
32. Therapeutics 10%